NAOMI BARTON: Open Payments
NPI 1053792275 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $91 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $122 |
| Amgen Inc. | 3 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $66 |
| Alexion Pharmaceuticals, Inc. | 2 | $44 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
Products named: Fabhalta, UPLIZNA, Kerendia, ULTOMIRIS, Vanrafia, FUROSCIX.
Industry payments across PA — which companies pay providers there.
